Anxo Pharmaceutical Co., Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 849.949 million compared to TWD 704.763 million a year ago. Operating income was TWD 52.327 million compared to operating loss of TWD 22.077 million a year ago. Net income was TWD 28.651 million compared to net loss of TWD 28.940 million a year ago. Basic earnings per share was TWD 0.69 compared to basic loss per share of TWD 0.71 a year ago.